Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Neuroscience and Biomedical Engineering | journal | 0.118 Q4 | 1 | 3 | 6 | 416 | 1 | 6 | 0.17 | 138.67 | |
2 | Current Medicinal Chemistry | journal | 1.085 Q2 | 202 | 276 | 956 | 36282 | 3493 | 901 | 3.39 | 131.46 | |
3 | Current Pharmaceutical Design | journal | 1.069 Q1 | 183 | 581 | 1906 | 75638 | 5822 | 1740 | 2.73 | 130.19 | |
4 | Current Drug Targets | journal | 1.172 Q1 | 119 | 241 | 469 | 26140 | 1431 | 426 | 2.58 | 108.46 | |
5 | Current Neuropharmacology | journal | 1.385 Q1 | 103 | 120 | 169 | 12931 | 723 | 150 | 3.15 | 107.76 | |
6 | Current Topics in Medicinal Chemistry | journal | 0.879 Q2 | 133 | 294 | 694 | 31134 | 1958 | 611 | 2.62 | 105.90 | |
7 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 11 | 76 | 1147 | 143 | 63 | 1.25 | 104.27 | ||
8 | Current Molecular Pharmacology | journal | 1.090 Q1 | 49 | 37 | 73 | 3579 | 167 | 62 | 2.19 | 96.73 | |
9 | Current Organic Chemistry | journal | 0.566 Q3 | 112 | 196 | 631 | 18613 | 1182 | 561 | 1.85 | 94.96 | |
10 | Mini-Reviews in Medicinal Chemistry | journal | 0.728 Q2 | 107 | 186 | 377 | 17338 | 1120 | 354 | 2.46 | 93.22 | |
11 | Current Cancer Drug Targets | journal | 1.271 Q1 | 103 | 84 | 221 | 7769 | 816 | 205 | 2.78 | 92.49 | |
12 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q1 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 | |
13 | Current Genomics | journal | 1.227 Q2 | 77 | 53 | 155 | 4773 | 392 | 136 | 1.81 | 90.06 | |
14 | Current Diabetes Reviews | journal | 1.396 Q1 | 68 | 67 | 126 | 5933 | 422 | 117 | 2.96 | 88.55 | |
15 | Current Stem Cell Research and Therapy | journal | 0.723 Q2 | 63 | 91 | 186 | 7987 | 422 | 168 | 2.12 | 87.77 | |
16 | Current Immunology Reviews | journal | 0.271 Q4 | 23 | 19 | 58 | 1629 | 36 | 51 | 0.32 | 85.74 | |
17 | Current Protein and Peptide Science | journal | 0.894 Q1 | 96 | 89 | 231 | 7561 | 533 | 203 | 2.33 | 84.96 | |
18 | Current Gene Therapy | journal | 1.323 Q1 | 80 | 43 | 143 | 3620 | 462 | 134 | 3.06 | 84.19 | |
19 | CNS and Neurological Disorders - Drug Targets | journal | 1.003 Q1 | 96 | 144 | 500 | 12082 | 1247 | 440 | 2.47 | 83.90 | |
20 | Current Aging Science | journal | 0.494 Q2 | 42 | 35 | 97 | 2866 | 154 | 91 | 1.49 | 81.89 | |
21 | Current Alzheimer Research | journal | 1.207 Q2 | 103 | 161 | 329 | 13050 | 1104 | 313 | 3.12 | 81.06 | |
22 | Current Rheumatology Reviews | journal | 0.332 Q3 | 29 | 33 | 80 | 2660 | 88 | 73 | 1.81 | 80.61 | |
23 | Current Women's Health Reviews | journal | 0.159 Q3 | 16 | 18 | 76 | 1378 | 18 | 69 | 0.05 | 76.56 | |
24 | Mini-Reviews in Organic Chemistry | journal | 0.365 Q3 | 43 | 44 | 124 | 3312 | 148 | 112 | 1.02 | 75.27 | |
25 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 15 | 69 | 1119 | 78 | 65 | 0.96 | 74.60 | ||
26 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.587 Q2 | 28 | 20 | 61 | 1492 | 119 | 59 | 1.76 | 74.60 | |
27 | Current Cardiology Reviews | journal | 1.071 Q1 | 58 | 40 | 134 | 2921 | 316 | 121 | 1.60 | 73.03 | |
28 | Current Organic Synthesis | journal | 0.566 Q3 | 55 | 71 | 192 | 5109 | 342 | 182 | 1.90 | 71.96 | |
29 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 35 | 134 | 2490 | 247 | 122 | 1.59 | 71.14 | ||
30 | Recent Patents on Nanotechnology | journal | 0.394 Q2 | 36 | 26 | 59 | 1825 | 108 | 52 | 0.95 | 70.19 | |
31 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 70 | 1540 | 91 | 66 | 1.38 | 70.00 | ||
32 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.807 Q2 | 108 | 198 | 464 | 13188 | 1248 | 429 | 2.43 | 66.61 | |
33 | Current Respiratory Medicine Reviews | journal | 0.270 Q3 | 15 | 40 | 142 | 2596 | 60 | 116 | 0.18 | 64.90 | |
34 | Current Vascular Pharmacology | journal | 0.890 Q2 | 69 | 87 | 299 | 5574 | 629 | 252 | 2.15 | 64.07 | |
35 | Recent Patents on Biotechnology | journal | 0.306 Q3 | 42 | 29 | 70 | 1811 | 69 | 62 | 0.83 | 62.45 | |
36 | Current Enzyme Inhibition | journal | 0.170 Q4 | 19 | 23 | 51 | 1435 | 17 | 44 | 0.33 | 62.39 | |
37 | Open Ornithology Journal | journal | 0.166 Q4 | 9 | 6 | 15 | 358 | 5 | 15 | 0.18 | 59.67 | |
38 | Current Metabolomics | journal | 4 | 6 | 3 | 353 | 1 | 3 | 0.33 | 58.83 | ||
39 | Current Pharmacogenomics and Personalized Medicine | journal | 0.118 Q4 | 20 | 15 | 79 | 872 | 24 | 73 | 0.24 | 58.13 | |
40 | Open Biotechnology Journal | journal | 0.127 Q4 | 18 | 40 | 69 | 2307 | 21 | 67 | 0.30 | 57.68 | |
41 | Current Drug Delivery | journal | 0.504 Q2 | 72 | 167 | 236 | 9569 | 523 | 224 | 2.15 | 57.30 | |
42 | Nanoscience and Nanotechnology - Asia | journal | 0.196 Q3 | 17 | 16 | 46 | 900 | 26 | 39 | 0.42 | 56.25 | |
43 | Current Hypertension Reviews | journal | 0.619 Q2 | 27 | 34 | 93 | 1858 | 134 | 83 | 1.38 | 54.65 | |
44 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.267 Q3 | 27 | 25 | 76 | 1341 | 74 | 67 | 0.96 | 53.64 | |
45 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.648 Q3 | 63 | 39 | 130 | 2067 | 264 | 119 | 2.21 | 53.00 | |
46 | Open Neuroimaging Journal | journal | 9 | 13 | 0 | 682 | 0 | 0 | 0.00 | 52.46 | ||
47 | Reviews on Recent Clinical Trials | journal | 0.484 Q2 | 35 | 42 | 111 | 2198 | 148 | 97 | 1.46 | 52.33 | |
48 | Current Drug Discovery Technologies | journal | 0.496 Q2 | 49 | 23 | 85 | 1202 | 130 | 82 | 1.65 | 52.26 | |
49 | Open Hypertension Journal | journal | 0.117 Q4 | 6 | 1 | 37 | 51 | 11 | 25 | 0.17 | 51.00 | |
50 | Current Cancer Therapy Reviews | journal | 0.183 Q4 | 17 | 21 | 86 | 1067 | 27 | 78 | 0.25 | 50.81 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®